Yucai Wang Selected Research

Fatigue

1/2020	Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis.
7/2019	Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yucai Wang Research Topics

Disease

70	Neoplasms (Cancer) 05/2024 - 01/2007
13	Lymphoma (Lymphomas) 05/2024 - 01/2019
12	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 01/2020
11	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 01/2019
10	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 01/2019
9	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2011
8	Infections 05/2024 - 03/2016
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 01/2019
7	Multiple Myeloma 04/2024 - 01/2016
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2023 - 01/2022
7	Hypoxia (Hypoxemia) 01/2023 - 01/2018
5	Cytokine Release Syndrome 11/2023 - 09/2020
5	Disease Progression 01/2023 - 03/2016
4	COVID-19 02/2024 - 09/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 01/2019
4	Inflammation (Inflammations) 09/2023 - 11/2017
4	Neoplasm Metastasis (Metastasis) 10/2019 - 08/2014
4	Fanconi Anemia (Fanconi's Anemia) 06/2014 - 03/2012
4	Osteosarcoma (Osteogenic Sarcoma) 04/2014 - 01/2007
3	Neutropenia 03/2024 - 03/2016
3	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 01/2022
3	Starvation 08/2023 - 01/2018
3	Hodgkin Disease (Hodgkin's Disease) 04/2023 - 01/2018
2	Cytopenia 01/2024 - 06/2022
2	Bacterial Infections (Bacterial Infection) 01/2023 - 01/2022
2	Neoplasm Micrometastasis 01/2023 - 01/2023
2	Stroke (Strokes) 12/2022 - 08/2010
2	Fibrosis (Cirrhosis) 06/2022 - 09/2018
2	Dysbiosis 01/2022 - 01/2022
2	Hyperthermia 01/2022 - 10/2020
2	Atrial Fibrillation 01/2022 - 01/2021
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2022 - 08/2010
2	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2021
2	cell-associated neurotoxicity 01/2022 - 11/2021
2	Body Weight (Weight, Body) 01/2021 - 10/2013
2	Fatigue 01/2020 - 07/2019

Drug/Important Bio-Agent (IBA)

15	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2022
12	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2012
8	GoldIBA 01/2023 - 01/2012
7	ibrutinibIBA 01/2024 - 01/2020
7	Immune Checkpoint InhibitorsIBA 04/2023 - 07/2019
6	venetoclaxIBA 03/2024 - 01/2020
6	EnzymesIBA 10/2023 - 03/2013
6	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 05/2007
5	axicabtagene ciloleucelIBA 01/2023 - 01/2021
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 04/2014
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2022
4	ProdrugsIBA 01/2023 - 01/2018
4	AlbuminsIBA 01/2023 - 12/2016
4	Monoclonal AntibodiesIBA 01/2022 - 01/2007
4	Oxygen (Dioxygen)IBA 01/2020 - 01/2018
4	Therapeutic UsesIBA 10/2019 - 02/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 01/2022
3	VaccinesIBA 02/2024 - 01/2007
3	CytokinesIBA 02/2024 - 01/2020
3	brexucabtagene autoleucelIBA 11/2023 - 06/2022
3	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2018
3	Carrier Proteins (Binding Protein)IBA 01/2023 - 03/2012
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 11/2017
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 03/2016
3	Programmed Cell Death 1 ReceptorIBA 12/2021 - 01/2018
3	LipidsIBA 04/2021 - 01/2019
3	PolymersIBA 02/2020 - 01/2018
3	Liposomes (Liposome)IBA 03/2019 - 05/2017
2	AntigensIBA 05/2024 - 02/2024
2	Methotrexate (Mexate)FDA LinkGeneric 02/2024 - 12/2022
2	mRNA VaccinesIBA 02/2024 - 12/2023
2	zanubrutinibIBA 01/2024 - 01/2022
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 01/2023
2	Alkylating AgentsIBA 11/2023 - 04/2022
2	LigandsIBA 10/2023 - 07/2019
2	Metal-Organic FrameworksIBA 10/2023 - 12/2021
2	Collagenases (Collagenase)FDA Link 10/2023 - 01/2022
2	Bendamustine Hydrochloride FDA Link 10/2023 - 01/2022
2	A-Form DNA (A-DNA)IBA 01/2023 - 01/2018
2	pirtobrutinibIBA 01/2023 - 11/2022
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 01/2021
2	Betaine (C.B.B.)FDA Link 01/2022 - 04/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 10/2019
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2020
2	AcidsIBA 02/2020 - 01/2020
2	N-end cysteine peptide tumor-homing peptideIBA 12/2019 - 08/2019
2	Photosensitizing Agents (Photosensitizers)IBA 08/2019 - 02/2018

Therapy/Procedure

60	Therapeutics 05/2024 - 08/2010
10	Radiotherapy 05/2024 - 09/2014
10	Immunotherapy 11/2022 - 01/2007
9	Drug Therapy (Chemotherapy) 01/2024 - 01/2013
5	Aftercare (After-Treatment) 02/2024 - 01/2018
4	Photothermal Therapy 05/2023 - 01/2018
3	Phototherapy (Light Therapy) 01/2021 - 10/2019
2	Transplantation 02/2024 - 01/2022
2	Lasers (Laser) 05/2023 - 10/2020
2	Length of Stay 01/2023 - 12/2022
2	Oral Administration 01/2022 - 10/2013
2	Photochemotherapy (Photodynamic Therapy) 01/2020 - 12/2019
2	Intravenous Injections 01/2020 - 01/2018